Angiolab, Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the development and manufacturing of innovative medical devices and diagnostic solutions. The company focuses on advancing healthcare technologies, particularly in the fields of vascular intervention and minimally invasive procedures. Angiolab aims to enhance patient outcomes through its commitment to research and development, leveraging cutting-edge technology to address unmet medical needs in the global market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#61 in Daejeon

#1,012 in South Korea

#51,761 in the World

Daejeon, South Korea

Angiolab, Inc.

Forward Citations = 31

30 inventors:

Min-Young Kim (11 out of 13 patents)

Byung-Young Park (4 out of 4 patents)

Chang-Hee Moon (3 out of 3 patents)

4. Eun-Kyu Park (3 out of 3 patents)

5. Kyoung-Mi Kim (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angiolab, Inc.. Retrieved from https://idiyas.com/company/angiolab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]